A Ran-binding protein facilitates nuclear import of human papillomavirus type 16.
Kun-Yi LaiMatteo RizzatoInci AydinRuth Villalonga-PlanellsHannes C A DrexlerMario SchelhaasPublished in: PLoS pathogens (2021)
Human papillomaviruses (HPVs) utilize an atypical mode of nuclear import during cell entry. Residing in the Golgi apparatus until mitosis onset, a subviral complex composed of the minor capsid protein L2 and viral DNA (L2/vDNA) is imported into the nucleus after nuclear envelope breakdown by associating with mitotic chromatin. In this complex, L2 plays a crucial role in the interactions with cellular factors that enable delivery and ultimately tethering of the viral genome to mitotic chromatin. To date, the cellular proteins facilitating these steps remain unknown. Here, we addressed which cellular proteins may be required for this process. Using label-free mass spectrometry, biochemical assays, microscopy, and functional virological assays, we discovered that L2 engages a hitherto unknown protein complex of Ran-binding protein 10 (RanBP10), karyopherin alpha2 (KPNA2), and dynein light chain DYNLT3 to facilitate transport towards mitotic chromatin. Thus, our study not only identifies novel cellular interactors and mechanism that facilitate a poorly understood step in HPV entry, but also a novel cellular transport complex.
Keyphrases
- binding protein
- genome wide
- label free
- gene expression
- mass spectrometry
- dna damage
- cell cycle
- transcription factor
- high resolution
- high throughput
- sars cov
- endothelial cells
- single molecule
- dna methylation
- protein protein
- stem cells
- high grade
- single cell
- cell therapy
- bone marrow
- induced pluripotent stem cells
- high speed
- mesenchymal stem cells
- hiv infected patients
- antiretroviral therapy